← Back to news
Y

Yahoo Finance

Are Wall Street Analysts Bullish on Morgan Stanley Stock?

Y

Brookfield to Buy Peakstone Realty Trust in $1.2 Billion Deal

Y

C3.ai (AI) Stays Central to AI Debate as Capital Intensity Challenges Investor Confidence

Y

Russia’s Largest Crypto Miner BitRiver Faces Bankruptcy as CEO Under House Arrest: Report

Y

RIA Edge 100 Firms Add Clients, Employees at Roughly Same Pace

Y

'It's All On Paper' – Gymshark Founder, Worth $1.4B, Says You Should Never Link Self-Worth With Money, Thinks It's 'Wildly Unproductive' Way To Live

Y

Tom Lee's BitMine Immersion added 41,000 ether as paper losses rise to $6 billion

Y

1 Under-the-Radar AI Stock With Explosive Growth Potential

Y

H.C. Wainwright Highlight Curative Potential of Legend Biotech Corporation (LEGN)’s Carvykti Despite Sales Miss

Y

Ardelyx, Inc. (ARDX) Gains TD Analysts Support Ahead of Q4 Results

Y

Analysts Bullish Ahead of Colorectal Cancer Readout for CytomX Therapeutics, Inc. (CTMX)

Y

Baird Updates Intellia Therapeutics, Inc. (NTLA)’s Financial Model Following Nex-Z Clinical Hold Removal

Y

Cattle Supply Crunch Weighs on Profit at Tyson Foods

Y

Taysha Gene Therapies, Inc. (TSHA) Gains Wells Fargo’s Support on Rett Syndrome Program Progress

Y

Janux Therapeutics, Inc. (JANX) Faces Platform Risk Amid Lack of Durability Data on JANX007

Y

Analyst Flags Kura Oncology, Inc. (KURA) for 2026 Milestones and Pipeline Expansion

Y

Goldman Sachs Notes VELA-2 Failure, Calls MoonLake Immunotherapeutics (MLTX) a High-Risk Play

Y

Here’s Why uniQure (QURE) Declined in Q4

Y

ExxonMobil Continues to Prove It's in a League of Its Own

Y

Celcuity (CELC) Draws Investor Attention as Precision Oncology Strategy Advances

Y

Europe just started building a ‘kill switch’ for U.S. tech — and the market isn’t priced for it, says this strategist

Y

Fed Chair Nominee Kevin Warsh Has Called Bitcoin The 'New Gold', Yet BTC Is Down 3%

Y

Where’s my refund? These 2 changes at the IRS could slow down your check this tax season

Y

Stifel Raised Nurix Therapeutics, Inc. (NRIX) Price Target to $35 and Maintains Buy Ahead of 2026 Catalysts

Y

Why Pharming, A Top 3% Biotech Stock, Just Took A Double-Digit Beating

Y

Jefferies Downgrades Amicus Therapeutics, Inc. (FOLD) to Buy And Lowers Price Target Amid Takeover Developments

Y

Rosenblatt Highlights Tax Incentives and Sales Execution as Q4 Upside Drivers for Fortinet, Inc. (FTNT)

Y

Amphenol Corporation (APH) Gains Attention After Dual Price Target Raises

Y

William Blair Notes Rambus Inc. (RMBS) Positioned as Top DRAM Memory Supplier

Y

TD Cowen Expects Dynatrace, Inc. (DT) to Deliver Above-Expectations Results

Y

Nextpower Inc. (NXT) Posts “Beat and Raise” Quarter, Supports Higher Valuation

Y

Needham Notes that Semiconductor Equipment Recovery Is Boosting Nova Ltd. (NVMI)

Y

Mosaic Stock: Analyst Estimates & Ratings

Y

Retirees and Income Investors Missed QQQM’s 108% Return By Focusing On The Wrong Thing

Y

Analysts Cut Profit Predictions Amid Elon Musk's Big Spending Plans, Fewer EV Models

Y

Treasury Yields Mixed Ahead of Labor Data

Y

Prediction: 2026 Will Be the Year of Ethereum (ETH)

Y

Bitcoin drops below $78,000 support amid record ETF outflows

Y

Should You Consider Investing in Knight-Swift Transportation Holdings (KNX)?

Y

Beta Bionics receives FDA warning letter

Y

Do Wall Street Analysts Like Super Micro Computer Stock?

Y

Delaying Benefits to Age 70 Backfires When Federal Garnishment Takes Its Cut

Y

FMC Corporation (FMC) Fell After Disappointing Results

Y

Analysts Love These 3 High-Dividend-Yield Winners in Choppy Markets

Y

Skyworks Solutions (SWKS) Traded Down in Q4. Here’s Why

Y

Crypto Investment Products See Record Outflows Amid BTC, ETH Price Slump

Y

Linq raises $20M to enable AI assistants to live within messaging apps

Y

Earnings Beat Lifted Dollar General (DG) in Q4

Y

Copart Stock Outlook: Is Wall Street Bullish or Bearish?

Y

Should You Buy AMD Before Feb. 3?

Y